Professor Zhengming Chen, Richard Peto Professor of Epidemiology at the University of Oxford and Principal Investigator of the China Kadoorie Biobank, will share how the power of biobanks can be harnessed in diverse populations for precision health, at this inaugural National Heart and Lung Institute (NHLI) Masterclass.
The China Kadoorie Biobank is one of the world’s largest prospective studies and is a long-term collaboration between the University of Oxford, Peking University and the Chinese Academy of Medical Sciences.
More than 512,000 adults were recruited from ten geographically defined and diverse areas of China between 2004 and 2008 and extensive data was collected at baseline and subsequent periodic resurveys. The health of participants has been monitored over about two decades.
The talk will run from 17.15-18:00, followed by a drinks reception and networking.
Please register your attendance by clicking the ‘Register Now’ button on the left-hand side of the page.
Speaker Biography
Professor Zhengming Chen is an elected member of Academia Europaea and inaugural Richard Peto Chair Professor in Epidemiology at the Nuffield Department of Population Health, University of Oxford. He qualified in medicine at Shanghai Medical University in 1983, followed by further postgraduate training in public Health in China and DPhil in Epidemiology at University of Oxford in 1991.
His main research concerns causes, prevention and treatment of major chronic diseases of adults and development of precision health, using big data and multi-omics approaches. Over the last three decades, he has led several large randomised trials of stroke, heart diseases and certain cancers involving in total >100,000 patients, leading to major changes of international guidelines and clinical practice.
In 2003, he initiated, designed and established in collaboration with research institutes in China, and has led ever since as UK PI, the China Kadoorie Biobank of >512,000 adults (www.ckbiobank.org). He has published >685 papers (h-Index: >120; total citations>120,000), with expertise in epidemiology, proteomics, genomics, precision medicine and clinical trials. He holds honorary professorship in a number of institutes and sits on various advisory committees in the UK and China.